Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAura Biosciences
About this trial
To assess subject-centric real-world evidence of QoL outcomes in subjects enrolled in the global Phase 3 AU-011-301 clinical trial.
Eligibility criteria
Qualifiers
Have enrolled in the Aura-sponsored clinical trial AU-011-301.
Access to a connected device (i.e., smartphone, laptop, or tablet)
Disqualifiers
None
Trial design
Treatments tested in this trial
- Non-interventional, digital, patient-reported, real-world study
Treatment groups
15 Participants
are divided into 1 treatment groupSponsors and collaborators
Aura Biosciences
Lead sponsor
Vitaccess Ltd
Collaborator
Source ClinicalTrials.gov